Comparison of dual vs. triple oral metronomic chemotherapy using methotrexate, celecoxib with or without erlotinib in advanced head and neck squamous cell cancer: Real-world data and experience from a tertiary care center.

Authors: Rishi Prem Nair, Sanjay Santhyavu, Atul Gupta, Depanshu Aggarwal, Amith Mohan, Sujoy Fernandes, Bharti Devnani, Akanksha Solanki, Puneet Pareek

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e18038

Source: Full article

---

Abstract

e18038